A redox-activated theranostic nanoagent: toward multi-mode imaging guided chemo-photothermal therapy

Development of tumor microenvironment responsive and modulating theranostic nano-systems is of great importance for specific and efficient cancer therapy. Herein, we report a redox-sensitive nanoagent combining manganese dioxide (MnO 2 ) and gold nanoshell coated silicon nanoparticles for synergisti...

Full description

Saved in:
Bibliographic Details
Published inChemical science (Cambridge) Vol. 9; no. 33; pp. 6749 - 6757
Main Authors Zhang, Ting-Ting, Xu, Cong-Hui, Zhao, Wei, Gu, Yu, Li, Xiang-Ling, Xu, Jing-Juan, Chen, Hong-Yuan
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 07.09.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Development of tumor microenvironment responsive and modulating theranostic nano-systems is of great importance for specific and efficient cancer therapy. Herein, we report a redox-sensitive nanoagent combining manganese dioxide (MnO 2 ) and gold nanoshell coated silicon nanoparticles for synergistic chemo-photothermal therapy of hypoxia solid tumors. In highly reducing tumor tissues, the outer MnO 2 nanosheet with the loaded drug would be dissociated by intracellular glutathione (GSH), resulting in on-demand drug release, as well as generating Mn 2+ ions which provided high contrast magnetic resonance imaging (MRI), and fluorescence imaging (FI) in vitro and in vivo . While upon near-infrared (NIR) light irradiation, the gold nanoshell modulated the hypoxic tumor microenvironment via increasing blood flow, achieving enhanced photothermal therapy (PTT) and chemotherapy. After tail vein injection into tumor-bearing mice and monitoring in real time, the intelligent redox-activated nanoagent exhibited high tumor accumulation and powerful synergistic chemo-photothermal therapy efficiency. The proposed work developed a noninvasive strategy to modulate the tumor microenvironment and enhance the anticancer therapeutic effect. We believe that this single nano-platform exhibits promising potential as a comprehensive theranostic agent to enhance the efficacies of synergistic cancer therapy.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to the work.
ISSN:2041-6520
2041-6539
DOI:10.1039/C8SC02446D